FGF18 alleviates hepatic ischemia-reperfusion injury via the USP16-mediated KEAP1/Nrf2 signaling pathway

Author:

Cong Weitao1ORCID,Tong Gaozan1,Chen Yiming2,Chen Xixi1,fan junfu1,Zhu Kunxuan1,hu Zijing1,Li Santie1,zhu junjie1,feng jianjun1,wu zhaohang1,hu zhenyu1,zhou bin3,jin litai1ORCID,shen jingling4,Li Xiaokun1

Affiliation:

1. Wenzhou Medical University

2. The Second Affiliated Hospital of Wenzhou Medical University

3. The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University

4. wenzhou university

Abstract

Abstract Hepatic ischemia-reperfusion injury (IRI) is a common complication that occurs during hepatic resection and liver transplantation. However, the mechanisms underlying hepatic IRI have not been fully elucidated. Here, we aimed to explore the role of fibroblast growth factor 18 (FGF18) in hepatic IRI and the underlying mechanisms. In this work, we found that FGF18 was upregulated in the livers of human and mice subjected to IRI. Hepatic stellate cells (HSCs) secreted FGF18 and protected against IRI-induced hepatocytes apoptosis, inflammation and oxidative stress. Liver-specific FGF18 overexpression effectively alleviated I/R-induced liver injury, while aggravated in mice with HSCs-specific FGF18 deletion. Mechanistically, FGF18 treatment reduced the mRNA and protein levels of ubiquitin carboxyl-terminal hydrolase 16 (USP16), leading to increased ubiquitination levels of Kelch Like ECH Associated Protein 1 (KEAP1) and the activation of nuclear factor erythroid 2-related factor 2 (Nrf2). In addition, USP16 interacted and deubiquitinated KEAP1 via K48-linked ubiquitination. More importantly, FGF18-induced Nrf2 directly bound to the promoter of USP16 and thus formed a negative feedback loop with USP16. Collectively, our results show that FGF18 alleviates hepatic IRI mainly by elevating the ubiquitination level of KEAP1 via downregulation of USP16 and thereby activating the Nrf2 signaling pathway, suggesting that FGF18 may represent a promising therapeutic approach for hepatic IRI.

Publisher

Research Square Platform LLC

Reference39 articles.

1. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning;Jaeschke H;Am J Physiol Gastrointest Liver Physiol,2003

2. Hepatic ischemia/reperfusion: mechanisms of tissue injury, repair, and regeneration;Konishi T;Gene Expr,2017

3. Ethanol, oxidative stress, and cytokine-induced liver cell injury;Hoek JB;Alcohol,2002

4. Current knowledge on oxidative stress in hepatic ischemia/reperfusion;Elias-Miró M;Free Radic Res,2013

5. A review of FGF18: Its expression, signaling pathways and possible functions during embryogenesis and post-natal development;Haque T;Histol Histopathol,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3